Search clinical trials for: tinzaparin sodium

Total 10580 results

Cardiff University
National Institute for Health Research, United Kingdom; Wales Cancer Trials...

Terminated

Anticoagulation Length in Cancer Associated Thrombosis (ALICAT)

Cancer | Thrombosis | Deep Vein Thrombosis | Venous Thromboembolism | Pulmonary Embolus

United Kingdom
Rigel Pharmaceuticals

Completed

Efficacy and Safety Study of Fostamatinib Disodium Tablets to Treat T-Cell Lymphoma

T Cell Lymphoma

United States, Canada
Hospital Universitari de Bellvitge
LEO Pharma

Completed

Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis

Venous Thromboembolism

Spain
Complejo Hospitalario Xeral-Calde
LEO Pharma

Completed

Tinzaparin in the Treatment of the Acute Pulmonary Embolism

Acute Pulmonary Embolism

Spain
Aalborg University Hospital
Aalborg University

Completed

Evaluation of Long-Term Sequelae After Thrombophlebitis, i.e. Deep Venous Thrombosis of the Lower Extremities

Deep Venous Thrombosis

Denmark
Duke University
Celgene Corporation

Completed

Innohep for Prophylaxis of Venous Thromboembolism in Brain Tumor Patients

Primary Brain Tumor

United States
Clinica San Camilo, Argentina

Unknown

Nebulized Heparin in Severe Acute Respiratory Syndrome COVID-19 (NEBUHEPA)

Pneumonia | Covid19

Argentina
LEO Pharma

Completed

Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein Thrombosis

Deep Vein Thrombosis

Bulgaria, Croatia, Czechia, France, Germany, Poland, Romania, Serbia, Spain
Centre Hospitalier Universitaire, Amiens

Recruiting

Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein Thrombosis (Aticks Live)

Inflammatory Response | Deep Vein Thrombosis

France
Ottawa Hospital Research Institute
Canadian Venous Thromboembolism Clinical Trials and Outcomes Research (CanVECTOR)...

Terminated

WAVe Study - Weight Adjusted Dalteparin for Patients Over 90 kg With Acute Cancer Associated Venous Thromboembolism (WAVe)

Obesity | Cancer | Venous Thromboembolism

Canada
Lawson Health Research Institute

Completed

A New Anticoagulation Method Using Dalteparin in Quotidian and Nocturnal Home Hemodialysis Patients

Kidney Failure

Canada
Pfizer

Completed

Effectiveness And Safety Of Dalteparin In Patients With Acute Coronary Syndromes Without ST Elevations In Clinical Practice

Acute Coronary Syndrome

India
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Completed

Dalteparin in Preventing DVT in Participants With Cancer

Soft Tissue Sarcoma | Lymphoma | Plasma Cell Myeloma | Bone Sarcoma | Femur Fracture | Metastatic Neoplasm | Pathologic Fracture

United States
University Medical Centre Ljubljana

Completed

Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis (REVETR)

Superficial Thrombophlebitis

Slovenia
Medical University of Vienna

Terminated

Thromboprophylaxis in Critically Ill Patients

Venous Thromboembolism

Austria
Galician Research Group on Digestive Tumors
LEO Pharma

Recruiting

TINzaparin Prophylaxis in Patients With Metastatic Colorectal Cancer (PROTINCOL)

Thromboembolism | Colorectal Cancer Metastatic

Spain
Ottawa Hospital Research Institute

Completed

Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal Cancer (PERIOP-01)

Adenocarcinoma of the Colon

Canada, France, Belgium
Pfizer

Completed

Fragmin for the Treatment of Acute VTE in Pediatric Cancer Patients

Venous Thromboembolism

United States, Norway, Russian Federation, Slovenia, Spain
Groupe Hospitalier Pitie-Salpetriere
Assistance Publique Hopitaux De Marseille

Completed

Venous Thromboprophylaxis in Bariatric Surgery (OBSUD)

Obesity
Ontario Clinical Oncology Group (OCOG)
Pfizer

Completed

Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients

Venous Thromboembolism | Brain Tumors

United States, Canada, Australia, Italy
Ain Shams University

Unknown

Sildenafil Versus Low Molecular Weight Heparin in Fetal Growth Restriction Treatment

Fetal Growth Restriction | Fetal Growth Abnormality

Egypt
Hospital Universitario Infanta Leonor

Completed

Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)

Covid19 | Thrombosis

Spain
Ottawa Hospital Research Institute
LEO Pharma

Completed

The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean Section

Deep Vein Thrombosis

Canada
Lawson Health Research Institute
Pfizer; Canadian Institutes of Health Research (CIHR)

Unknown

PERIOP 2 - A Safety and Effectiveness of LMWH vs Placebo Bridging Therapy for Patients on Long Term Warfarin Requiring Temporary Interruption of Warfarin.

Stroke

India, Canada
Maisonneuve-Rosemont Hospital

Completed

Study of the Bioaccumulation of Tinzaparin in Renally Impaired Patients When Given at Prophylactic Doses (STRIP)

Renal Insufficiency, Chronic | Deep Venous Thrombosis, Protection Against

Canada
Children's Oncology Group
National Cancer Institute (NCI)

Completed

Sodium Thiosulfate in Preventing Hearing Loss in Young Patients Receiving Cisplatin for Newly Diagnosed Germ Cell Tumor, Hepatoblastoma, Medulloblastoma, Neuroblastoma, Osteosarcoma, or Other Malignancy

Sarcoma | Ovarian Cancer | Brain Tumor | Ototoxicity | Neuroblastoma | Liver Cancer | Central Nervous System Tumor | Extragonadal Germ Cell Tumor | Childhood Germ Cell Tumor

Canada, United States, Australia
GlaxoSmithKline

Completed

Hemorrhage Risk Prescribed Arixtra

Thrombosis, Venous
University of Calgary
LEO Pharma

Completed

Safety and Efficacy of Therapeutic Anticoagulation With Tinzaparin During Pregnancy Via Weight-based Dosing

Venous Thromboembolism

Canada
Lawson Health Research Institute
Pfizer

Completed

The Catheter Study: Central Venous Catheter Survival in Cancer Patients Using Low Molecular Weight Heparin (Dalteparin) for the Treatment of Deep Vein Thrombosis

Embolism and Thrombosis

Canada
University of Delaware

Completed

Effects of Acute Dietary Sodium on Cerebrovascular Reactivity and Blood Pressure Reactivity

Blood Pressure | Cerebrovascular Reactivity

United States
M.D. Anderson Cancer Center
Eisai Inc.

Completed

Dalteparin for Primary Venous Thromboembolism (VTE) Prophylaxis in Pancreatic Cancer Patients

Pancreatic Cancer | Venous Thromboembolism

United States
Institut d'Anesthesiologie des Alpes Maritimes
Université de Nice Sophia Antipolis; Medical University of Grenoble

Completed

Preventive Sodium Lactate and Traumatic Brain Injury

Head Trauma

France
Radboud University Medical Center

Unknown

The Effect Lactate Administration on Cerebral Blood Flow During Hypoglycemia

Type1diabetes | Hypoglycemia Unawareness

Netherlands
McGill University

Completed

Impact of NaHCO3- on Exercise Hyperpnea

Pulmonary Ventilation

Canada
Austin Health

Completed

Bicarbonate and Lipocalin in Systemic Inflammatory Response Syndrome (SIRS) Study (BLISS)

Systemic Inflammatory Response Syndrome | Renal Impairment | Oliguria

Australia
Medical University of Graz

Completed

Blood Gas Analysis and Buffering In Cardiac Arrest (BABICA)

Cardiac Arrest

Austria
Brigham and Women's Hospital

Completed

Dietary Salt Intake and Vascular Function

Healthy

United States
Osaka General Medical Center

Completed

Prevention of Contrast-Induced Nephropathy With Sodium Bicarbonate Bolus Injection

Emergent Coronary Procedure

Japan
Pfizer

Completed

Evaluation of Dalteparin for Long-term (One Year) Treatment of Blood Clots in Subjects With Cancer

Cancer

United States, Canada, Spain, Austria, Netherlands
University of Florence

Terminated

LMWH to Prevent Preeclampsia and Fetal Growth Restriction

Preeclampsia
Eastern Cooperative Oncology Group
National Cancer Institute (NCI)

Completed

Dalteparin and Radiation Therapy in Treating Patients With Newly Diagnosed Supratentorial Glioblastoma Multiforme

Brain and Central Nervous System Tumors

United States
Azidus Brasil

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Subcutaneous Single Dose

Healthy

Brazil
St. Joseph's Healthcare Hamilton
LEO Pharma; Heart and Stroke Foundation of Ontario

Terminated

Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney Failure

Venous Thrombosis | Pulmonary Embolism

Canada
Ottawa Hospital Research Institute
LEO Pharma

Completed

Thromboprophylaxis for Patients Undergoing Surgical Resection for Colon Cancer (PERI-OP)

Cancer | Deep Vein Thrombosis | Pulmonary Embolism

Canada
Azidus Brasil
Blau Farmaceutica S.A.

Completed

Pharmacodynamics Study of Enoxalow Compared to Clexane in Healthy Subjects After Intravenous Administration

Healthy

Brazil
Duke University
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Effectiveness of Bridging Anticoagulation for Surgery (The BRIDGE Study)

Atrial Fibrillation | Arterial Thromboembolic Events

United States
Thomas Decker Christensen

Completed

Coagulation Profile in Patients Undergoing Video Assisted Thorascopic Surgery (VATS) for Lung Cancer (COPPVATS)

Lung Cancer

Denmark
Lars Wiuff Andersen
University of Aarhus

Recruiting

Bicarbonate for In-Hospital Cardiac Arrest (BIHCA)

Cardiac Arrest

Denmark
Gladwin, Mark, MD

Completed

Oral Nitrite in Adults With Metabolic Syndrome and Hypertension (ONTX)

Hypertension | Metabolic Syndrome

United States
Azienda Sanitaria ASL Avellino 2

Unknown

Effects of Short-chain Fatty Acids on Inflammatory and Metabolic Parameters in Maintenance Hemodialysis (PLAN)

Endstage Renal Disease

Search clinical trials for: tinzaparin sodium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Korea

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations